Lip and Oral Cavity Cancer
📧 Sign up to get email alerts when something new happens for Lip and Oral Cavity Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders [EARLY_Phase 1]
A Phase 1 study evaluating multimodal imaging for surveillance in patients with oral potentially malignant disorders; currently active but n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin [Phase 1]
Phase 1 trial evaluating the addition of M3814 (peposertib), a DNA-PK inhibitor, to radiation therapy in patients with advanced head and nec…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin [Phase 3]
Phase 3 clinical trial update on radiation plus cetuximab versus radiation plus non-cisplatin chemotherapy for head and neck cancer patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating donor natural killer cells with cyclophosphamide and etoposide in children and young adults with relapsed or refr…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Tozuleristide as a fluorescent tumor marking agent for imaging oral cavity squamous cell carcinoma and…
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating Xevinapant added to standard radiation therapy plus cisplatin/carboplatin for head and neck cancers has been withdr…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin [Phase 2]
Phase 2 trial evaluating sodium thiosulfate to prevent cisplatin-induced ototoxicity in patients with head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for SB-715992 in patients with recurrent or metastatic head and neck cancer; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia [Phase 2]
Phase 2 trial evaluating Bowman-Birk inhibitor concentrate to prevent cancer in patients with oral leukoplakia. The study is completed with …
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer [Phase 1]
Phase 1 trial of ONYX-015 with cisplatin and fluorouracil for advanced head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a gene therapy approach to prevent progression to cancer in premalignant lesions of the lip and oral cav…